US2021198742A1PendingUtilityA1

Methods for simultaneous amplification of target loci

Assignee: NATERA INCPriority: May 18, 2010Filed: Mar 9, 2021Published: Jul 1, 2021
Est. expiryMay 18, 2030(~3.8 yrs left)· nominal 20-yr term from priority
C12Q 1/6844C12Q 1/6883C12Q 1/6851C12Q 1/6848C12Q 2600/156C12Q 1/6855C12Q 1/6809C12Q 1/6811C12Q 1/6874C12Q 1/6858C12Q 1/6869
79
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for enriching and sequencing cell-free DNA, comprising:
 tagging each strand of cell-free DNA isolated from a biological sample with a molecular barcode to obtain barcoded DNA;   amplifying the barcoded DNA by universal amplification to obtain a sequencing library;   enriching for a plurality of target loci from the sequencing library using hybrid capture probes; and   performing high-throughput sequencing to sequence the enriched target loci and determine whether the target loci comprise a cancer-associated mutation.   
     
     
         2 . The method of  claim 1 , wherein the biological sample is a blood, plasma, serum, or urine sample. 
     
     
         3 . The method of  claim 1 , wherein the plurality of target loci comprises between 100 and 2,000 SNV loci. 
     
     
         4 . The method of  claim 1 , wherein the plurality of target loci comprises between 200 and 1,000 SNV loci. 
     
     
         5 . The method of  claim 1 , wherein the plurality of target loci comprises between 300 and 2,000 SNV loci. 
     
     
         6 . The method of  claim 1 , wherein the cell-free DNA are tagged with up to 1024 molecular barcodes. 
     
     
         7 . The method of  claim 1 , wherein the cell-free DNA are tagged with 1024-65536 molecular barcodes. 
     
     
         8 . The method of  claim 1 , wherein the cell-free DNA are tagged with the molecular barcodes through ligation. 
     
     
         9 . The method of  claim 1 , wherein sequence reads originating from the same original molecule are identified using the molecular barcodes. 
     
     
         10 . The method of  claim 1 , wherein the universal amplification introduces a sample-specific barcode, and wherein amplified DNAs of multiple samples are pooled together and sequenced in a single sequencing lane. 
     
     
         11 . A method for enriching and sequencing cell-free DNA, comprising:
 tagging cell-free DNA isolated from a biological sample with molecular barcodes to obtain barcoded DNA;   amplifying the barcoded DNA by universal amplification to obtain a sequencing library;   enriching for a plurality of target loci from the sequencing library using hybrid capture probes; and   performing high-throughput sequencing to sequence the enriched target loci and determine whether the target loci comprise a cancer-associated mutation.   
     
     
         12 . The method of  claim 11 , wherein the biological sample is a blood, plasma, serum, or urine sample. 
     
     
         13 . The method of  claim 11 , wherein the plurality of target loci comprises between 100 and 2,000 polymorphic loci. 
     
     
         14 . The method of  claim 11 , wherein the plurality of target loci comprises between 200 and 1,000 polymorphic loci. 
     
     
         15 . The method of  claim 11 , wherein the plurality of target loci comprises between 300 and 2,000 polymorphic loci. 
     
     
         16 . The method of  claim 11 , wherein the cell-free DNA are tagged with up to 1024 molecular barcodes. 
     
     
         17 . The method of  claim 11 , wherein the cell-free DNA are tagged with 1024-65536 molecular barcodes. 
     
     
         18 . The method of  claim 11 , wherein the cell-free DNA are tagged with the molecular barcodes through ligation. 
     
     
         19 . The method of  claim 11 , wherein sequence reads originating from the same original molecule are identified using the molecular barcodes. 
     
     
         20 . The method of  claim 11 , wherein the universal amplification introduces a sample-specific barcode, and wherein amplified DNAs of multiple samples are pooled together and sequenced in a single sequencing lane.

Join the waitlist — get patent alerts

Track US2021198742A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.